Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationHarry L.A. Janssen, Jordan J. Feld, Harald Hofer et al.|Journal of Hepatology|2016Cited by 273
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patientsGiuseppe Cabibbo, Calogero Cammà, Ciro Celsa et al.|Journal of Hepatology|2019Cited by 205
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Maria Grazia Grasso, Elba Llop et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 69
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction modelFrancesco Vizzutti, Filippo Schepis, Ciro Celsa et al.|Hepatology|2022Cited by 55
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future TrialsGiuseppe Cabibbo, Calogero Cammà, María Reig et al.|Liver Cancer|2021Cited by 50